Abstract CT303: A phase I pharmacokinetic and pharmacodynamic evaluation of the combination of everolimus and buparlisib for concurrent mTOR and PI3K pathway blockade in patients with advanced solid tumors

Taofeek K. Owonikoko, Fadlo R. Khuri, Colleen Lewis et al.|Cancer Research|2015

Cited by 0